Pain is one of the most difficult — and least talked about — parts of living with appendix cancer. For many patients, especially those with peritoneal involvement, pain isn’t just occasional. It can be chronic, exhausting, and deeply disruptive to everyday life.
A new clinical trial from UCLA Health is exploring a surprising but promising approach to pain management: virtual reality (VR). They are currently enrolling patients!
This study isn’t about curing cancer. It’s about something equally important for patients living with the disease — improving quality of life by helping people manage pain more effectively.

Why Appendix Cancer Patients Are Included
Appendix cancer falls under the category of gastrointestinal (GI) cancers, and patients often experience what’s known as visceral pain — deep abdominal pain that can be difficult to treat with standard medications alone.
That makes appendix cancer patients a relevant and important population for this trial.
Many of us know firsthand that pain management often relies heavily on opioids, which can come with side effects, tolerance, and long-term complications. This study is exploring whether non-drug tools can meaningfully reduce pain or make it easier to cope with.
What the Study Is Testing
Participants in the study use a VR headset at home over a period of time. The researchers are comparing three different experiences:
1. Skills-Based Virtual Reality Therapy
This isn’t just distraction. These VR experiences are designed to teach patients skills such as:
- Mindfulness
- Acceptance and Commitment Therapy (ACT)
- Relaxation and coping techniques
The goal is to help patients actively change how their brain processes pain, even after the headset comes off.
2. Distraction-Based Virtual Reality
These experiences are immersive and engaging — calming environments, visual journeys, or interactive content — meant to temporarily pull attention away from pain.
Distraction can be powerful, especially during pain flares or difficult days.
3. Sham (Control) VR
Some participants view non-immersive 2D content while wearing the headset. This allows researchers to understand whether true immersion is what makes the difference.
What the Researchers Are Measuring
This trial focuses on patient-reported outcomes, meaning the most important data comes directly from the people living with cancer.
They are tracking:
- Pain intensity
- How much pain interferes with daily life
- Physical activity and functioning
- Opioid use over time
- Overall quality of life
The study follows patients for about 60 days, looking for meaningful changes in how they feel and function.
For Appendix Cancer Patients, Pain is Often Under-recognized and Under-studied
Many treatments focus on survival — as they should — but living with cancer means more than just scans and labs.
If VR can:
- Reduce pain
- Improve coping
- Lower reliance on opioids
- Give patients tools they control themselves
that’s a meaningful step forward.
Even if VR doesn’t eliminate pain, helping patients feel more in control of their bodies and their days matters.
The Bigger Picture
This study is part of a growing movement toward integrative, patient-centered cancer care — where symptom management, mental health, and quality of life are treated as essential, not optional.
For a rare cancer community like ours, seeing appendix cancer included in innovative research like this is important. It signals that our pain, our experience, and our lives matter.
Click here to learn more about this clinical trial

Leave a Reply